featured
Effect of Diabetes Medications and Glycemic Control on Risk of HCC in Patients With NAFLD
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Hepatology (Baltimore, Md.)
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Effect of diabetes medications and glycemic control on risk of hepatocellular cancer in patients with nonalcoholic fatty liver disease
Hepatology 2022 Jun 01;75(6)1420-1428, JR Kramer, Y Natarajan, J Dai, X Yu, L Li, HB El-Serag, F KanwalFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.